Caryn G. McDowell
Geen lopende functies
Vermogen: 271 148 $ op 31-03-2024
Profiel
Caryn G.
McDowell formerly worked at Affymax, Inc., as Executive Director-Corporate Law from 2012 to 2013, Onyx Pharmaceuticals, Inc., as Associate General Counsel & Head-US Healthcare Law in 2013, InterMune, Inc., as SVP, Deputy General Counsel & Assistant Secretary from 2014 to 2015, Cytokinetics, Inc., as Chief Compliance Officer & General Counsel from 2016 to 2018, Revance Therapeutics, Inc., as Secretary, Senior VP & General Counsel, State of Massachusetts, as Assistant Attorney General-Medicaid Fraud Control, US Department of Health & Human Services (DC), as Senior Counsel-Inspector General Office from 2001 to 2004, and Quince Therapeutics, Inc., as Secretary, Chief Administrative & Legal Officer from 2020 to 2022.
Ms. McDowell received her undergraduate degree from the University of Michigan and graduate degree from Boston University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2023 | 255 800 ( 0.60% ) | 271 148 $ | 31-03-2024 |
Eerdere bekende functies van Caryn G. McDowell
| Bedrijven | Functie | Einde |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Chief Administrative Officer | 08-07-2022 |
| CYTOKINETICS, INCORPORATED | Compliance Officer | 01-05-2018 |
| INTERMUNE INC | Corporate Officer/Principal | 01-02-2015 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | General Counsel | 01-12-2013 |
| AFFYMAX, INC. | General Counsel | 01-01-2013 |
Opleiding van Caryn G. McDowell
| University of Michigan | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| REVANCE THERAPEUTICS, INC. | Health Technology |
| AFFYMAX, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
| State of Massachusetts | Government |
| US Department of Health & Human Services (DC) | Government |
